Synthesis of 5-isoxazol-3-yl-pyrimidine nucleosides as potential antileishmanial agents
- 1 July 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (13) , 2617-2620
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21202040, 21272058, 21172057)
- China Postdoctoral Science Foundation (2014M552007)
This publication has 38 references indexed in Scilit:
- Recent Developments in Drug Discovery for Leishmaniasis and Human African TrypanosomiasisChemical Reviews, 2014
- Fruitful Decade for Antileishmanial Compounds from 2002 to Late 2011Chemical Reviews, 2014
- 5-Alkynyl-2′-deoxyuridines: Chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cellsBioorganic & Medicinal Chemistry, 2007
- An Overview of Diazine Nucleoside AnaloguesCurrent Organic Chemistry, 2006
- Advances in leishmaniasisThe Lancet, 2005
- Antiviral drug discovery and development: Where chemistry meets with biomedicineAntiviral Research, 2005
- 5-(1-Substituted) Alkyl Pyrimidine Nucleosides as Antiviral (herpes) AgentsCurrent Medicinal Chemistry, 2004
- Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogsJournal of Medicinal Chemistry, 1993
- 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replicationJournal of Medicinal Chemistry, 1991
- Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridinesJournal of Medicinal Chemistry, 1991